ATE333502T1 - Verfahren zur herstellung von nukleinsäure- und polypeptidbanken durch in vivo rekombination und ihre verwendungen - Google Patents

Verfahren zur herstellung von nukleinsäure- und polypeptidbanken durch in vivo rekombination und ihre verwendungen

Info

Publication number
ATE333502T1
ATE333502T1 AT99972677T AT99972677T ATE333502T1 AT E333502 T1 ATE333502 T1 AT E333502T1 AT 99972677 T AT99972677 T AT 99972677T AT 99972677 T AT99972677 T AT 99972677T AT E333502 T1 ATE333502 T1 AT E333502T1
Authority
AT
Austria
Prior art keywords
nucleic acid
recombination
polypeptide
methods
replication
Prior art date
Application number
AT99972677T
Other languages
English (en)
Inventor
Andrew Raymon Morton Bradbury
Daniele Sblattero
Original Assignee
S I S S A Scuola Internaz Supe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S I S S A Scuola Internaz Supe filed Critical S I S S A Scuola Internaz Supe
Application granted granted Critical
Publication of ATE333502T1 publication Critical patent/ATE333502T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Ceramic Products (AREA)
  • Medicines Containing Plant Substances (AREA)
AT99972677T 1998-11-19 1999-11-18 Verfahren zur herstellung von nukleinsäure- und polypeptidbanken durch in vivo rekombination und ihre verwendungen ATE333502T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1998MI002509A IT1303776B1 (it) 1998-11-19 1998-11-19 Processo per la preparazione di genoteche, di polipeptidi utilizzandodette genoteche e i polipepti ottenuti.

Publications (1)

Publication Number Publication Date
ATE333502T1 true ATE333502T1 (de) 2006-08-15

Family

ID=11381090

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99972677T ATE333502T1 (de) 1998-11-19 1999-11-18 Verfahren zur herstellung von nukleinsäure- und polypeptidbanken durch in vivo rekombination und ihre verwendungen

Country Status (9)

Country Link
EP (1) EP1131421B1 (de)
AT (1) ATE333502T1 (de)
AU (1) AU3790300A (de)
CA (1) CA2350779A1 (de)
DE (1) DE69932446T2 (de)
ES (1) ES2268907T3 (de)
IL (2) IL143123A0 (de)
IT (1) IT1303776B1 (de)
WO (1) WO2000031246A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6780620B1 (en) 1998-12-23 2004-08-24 Bristol-Myers Squibb Company Microbial transformation method for the preparation of an epothilone
US6686154B2 (en) 2000-06-05 2004-02-03 Zyomyx, Inc. Screening of phage displayed peptides without clearing of the cell culture
ATE384129T1 (de) * 2001-11-22 2008-02-15 Univ Keio Künstliche antikörperbibliothek mit super- repertoire
EP2566512A1 (de) 2010-05-04 2013-03-13 Merrimack Pharmaceuticals, Inc. Antikörper gegen den epidermalen wachstumsfaktorrezeptor (egfr) und ihre verwendung
US8691231B2 (en) 2011-06-03 2014-04-08 Merrimack Pharmaceuticals, Inc. Methods of treatment of tumors expressing predominantly high affinity EGFR ligands or tumors expressing predominantly low affinity EGFR ligands with monoclonal and oligoclonal anti-EGFR antibodies
US9399672B2 (en) 2012-05-17 2016-07-26 The United States Of America, As Represented By The Secretary Department Of Health And Human Services Hepatitis C virus neutralizing antibody
WO2014065822A1 (en) 2012-10-26 2014-05-01 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Hepatitis c virus neutralizing epitopes, antibodies, and methods
TW201833140A (zh) 2017-01-09 2018-09-16 美商莫瑞麥克製藥公司 抗fgfr抗體及使用方法
TWI788340B (zh) 2017-04-07 2023-01-01 美商必治妥美雅史谷比公司 抗icos促效劑抗體及其用途
EP3694552A1 (de) 2017-10-10 2020-08-19 Tilos Therapeutics, Inc. Anti-lap-antikörper und verwendungen davon
EP3853252A1 (de) 2018-09-18 2021-07-28 Merrimack Pharmaceuticals, Inc. Anti-tnfr2-antikörper und verwendungen davon
CN113164780A (zh) 2018-10-10 2021-07-23 泰洛斯治疗公司 抗lap抗体变体及其用途
WO2020084034A1 (en) 2018-10-26 2020-04-30 F. Hoffmann-La Roche Ag Multispecific antibody screening method using recombinase mediated cassette exchange
CA3131953A1 (en) 2019-03-01 2020-09-10 Merrimack Pharmaceuticals, Inc. Anti-tnfr2 antibodies and uses thereof
JP7250950B2 (ja) 2019-03-29 2023-04-03 エフ． ホフマン－ラ ロシュ アーゲー 所定の構成の複数の発現カセットを標的指向組込みすることによってＦｃＲｎ発現細胞を作製するための方法
MX2022012005A (es) * 2020-03-27 2022-10-21 Ddbio Co Ltd Shang Hai Metodo para el despliegue de anticuerpo biespecifico en la superficie de celula de mamifero y vector.
US20230272056A1 (en) 2020-04-09 2023-08-31 Merck Sharp & Dohme Llc Affinity matured anti-lap antibodies and uses thereof
CN117430696A (zh) * 2022-07-22 2024-01-23 北京智仁美博生物科技有限公司 用于表达Fab片段库的重组系统

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117679A (en) * 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5728557A (en) * 1995-06-01 1998-03-17 Merck & Co., Inc. Method of making herpes simplex type 1 mutants and mutants so produced
CN1208456C (zh) * 1996-12-20 2005-06-29 诺维信公司 体内重组

Also Published As

Publication number Publication date
EP1131421A2 (de) 2001-09-12
IL143123A (en) 2009-11-18
ES2268907T3 (es) 2007-03-16
CA2350779A1 (en) 2000-06-02
DE69932446D1 (de) 2006-08-31
ITMI982509A1 (it) 2000-05-19
EP1131421B1 (de) 2006-07-19
WO2000031246A3 (en) 2000-08-17
WO2000031246A2 (en) 2000-06-02
AU3790300A (en) 2000-06-13
IL143123A0 (en) 2002-04-21
DE69932446T2 (de) 2007-01-04
IT1303776B1 (it) 2001-02-23

Similar Documents

Publication Publication Date Title
ATE333502T1 (de) Verfahren zur herstellung von nukleinsäure- und polypeptidbanken durch in vivo rekombination und ihre verwendungen
ATE460472T1 (de) Verfahren und zusammensetzungen zur synthese von nukleinsäuremolekülen unter verwendung multipler erkennungsstellen
ATE294229T1 (de) Verfahren zur trocknung von kompetenten zellen
DE69427997D1 (de) Hybrider mensch/tier faktor viii
ATE309342T1 (de) Verfahren zur herstellung in vitro von rekombinierten nucleotidsequenzen, und so hergestelte genbanken und sequenzen
ATE391789T1 (de) Verwendung einer vielzahl von rekombinationsstellen mit einzigartiger spezifität beim rekombinatorischen klonen
FI925986A0 (fi) Slumpartat bio-oligomer bibliotek, ett foerfarande foer syntetisering avdet samt ett foerfarande foer anvaendning av det
DE59708838D1 (de) Spiegelselektion und spiegelevolution von nucleinsäuren
DE69825496D1 (de) Verfahren zur Erstellung von Arrays hoher Dichte
ATE449850T1 (de) Mutanten von flt3-l und ihre verwendungen
EP0823914A4 (de) Systematische evoultion von liganden durch exponentielle anreicherung: gewebe-selex
DK0586618T3 (da) Anvendelse af nuklainsyreanaloger i diagnostiske og analytiske fremgangsmåder
AU3365095A (en) High throughput screening method for sequences or genetic alterations in nucleic acids
DE69739304D1 (de) Verfahren und Zusammensetzungen zur Bestimmung von Sequenzen von Nukleinsäure-Molekülen
ATE258598T1 (de) Verfahren zur proteinrückfaltung durch verwendung zwitterionischer wirkstoffe von niedrigem molekulargewicht
ATE317899T1 (de) Gefrierschutzproteine aus choristoneura sp., gene und verfahren zu ihrer verwendung
DE60106469D1 (de) Verfahren zur Herstellung von genetisch veränderten Lymphozyten Vorläuferzellen von Wirbeltieren und deren Gebrauch zur Produktion von heterologen Bindeproteinen
DK1098991T3 (da) Hidtil ukendte fremgangsmåder til identifikation af ligand- og målbiomolekyler
WO2003103600A3 (en) Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
DE60036794D1 (de) Proteomabbau
DE60233347D1 (de) Schnellreifende fluoreszierende proteine und verfahren zu deren anwendung
ATE522604T1 (de) Verfahren zur herstellung von proteinen durch elektropulsierung
DE50211528D1 (de) Verfahren zur herstellung einer normalisierten genbank aus nukleinsäure-exktrakten von bodenproben und deren verwendung
WO1998042868A3 (en) Screening method for proline-rich proteins
Amato A high-flying fix for ozone loss

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties